These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22183015)

  • 1. PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
    Yakemchuk VN; Jager PL; Chirakal R; Reid R; Major P; Gulenchyn KY
    Nucl Med Commun; 2012 Mar; 33(3):322-30. PubMed ID: 22183015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
    Koopmans KP; de Vries EG; Kema IP; Elsinga PH; Neels OC; Sluiter WJ; van der Horst-Schrivers AN; Jager PL
    Lancet Oncol; 2006 Sep; 7(9):728-34. PubMed ID: 16945767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
    Montravers F; Grahek D; Kerrou K; Ruszniewski P; de Beco V; Aide N; Gutman F; Grangé JD; Lotz JP; Talbot JN
    J Nucl Med; 2006 Sep; 47(9):1455-62. PubMed ID: 16954553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
    Koopmans KP; Neels OC; Kema IP; Elsinga PH; Sluiter WJ; Vanghillewe K; Brouwers AH; Jager PL; de Vries EG
    J Clin Oncol; 2008 Mar; 26(9):1489-95. PubMed ID: 18349401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
    Imperiale A; Rust E; Gabriel S; Detour J; Goichot B; Duclos B; Kurtz JE; Bachellier P; Namer IJ; Taïeb D
    J Nucl Med; 2014 Mar; 55(3):367-72. PubMed ID: 24343986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Added Diagnostic Value of
    Addeo P; Poncet G; Goichot B; Leclerc L; Brigand C; Mutter D; Romain B; Namer IJ; Bachellier P; Imperiale A
    J Gastrointest Surg; 2018 Apr; 22(4):722-730. PubMed ID: 29235002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
    Becherer A; Szabó M; Karanikas G; Wunderbaldinger P; Angelberger P; Raderer M; Kurtaran A; Dudczak R; Kletter K
    J Nucl Med; 2004 Jul; 45(7):1161-7. PubMed ID: 15235062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
    Santhanam P; Taïeb D
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbidopa-assisted
    Helali M; Addeo P; Heimburger C; Detour J; Goichot B; Bachellier P; Namer IJ; Taïeb D; Imperiale A
    Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data.
    Talbot JN; Kerrou K; Missoum F; Grahek D; Aide N; Lumbroso J; Montravers F
    Mol Imaging Biol; 2005; 7(4):257-61. PubMed ID: 16082495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
    Kuyumcu S; Adalet I; Sanli Y; Turkmen C; Ozkan ZG; Yilmazbayhan D
    Ann Nucl Med; 2012 Nov; 26(9):689-97. PubMed ID: 22802007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited role of carbidopa-assisted
    Imperiale A; Averous G; Helali M; Taieb D; Pessaux P; Goichot B; Addeo P; Bachellier P
    Ann Nucl Med; 2019 Sep; 33(9):697-707. PubMed ID: 31214959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
    Karunanithi S; Sharma P; Kumar A; Gupta DK; Khangembam BC; Ballal S; Kumar R; Kumar R; Bal C
    Eur J Radiol; 2014 Jan; 83(1):219-25. PubMed ID: 24191944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study.
    Karunanithi S; Bandopadhyaya GP; Sharma P; Kumar A; Singla S; Malhotra A; Gupta DK; Bal C
    Clin Nucl Med; 2014 Feb; 39(2):e121-8. PubMed ID: 23579970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
    Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Bowel Carcinoid: The "Dancing Bowel Sign" on 18F-FDOPA PET/CT.
    Helali M; Heimburger C; Rohr S; Goichot B; Imperiale A
    Clin Nucl Med; 2016 Dec; 41(12):944-945. PubMed ID: 27749424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
    Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
    J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
    Karunanithi S; Sharma P; Kumar A; Khangembam BC; Bandopadhyaya GP; Kumar R; Gupta DK; Malhotra A; Bal C
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1025-35. PubMed ID: 23525498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment.
    Lizarraga KJ; Allen-Auerbach M; Czernin J; DeSalles AA; Yong WH; Phelps ME; Chen W
    J Nucl Med; 2014 Jan; 55(1):30-6. PubMed ID: 24167081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDOPA PET/CT imaging of insulinoma revisited.
    Imperiale A; Sebag F; Vix M; Castinetti F; Kessler L; Moreau F; Bachellier P; Guillet B; Namer IJ; Mundler O; Taïeb D
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):409-18. PubMed ID: 25367749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.